183 related articles for article (PubMed ID: 10532519)
1. Tailored therapy using dobutamine and nitroglycerin in advanced heart failure.
Drazner MH; Solomon MA; Thompson B; Yancy CW
Am J Cardiol; 1999 Oct; 84(8):941-3, A7. PubMed ID: 10532519
[TBL] [Abstract][Full Text] [Related]
2. Cardiopulmonary effects of enoximone or dobutamine and nitroglycerin on mitral valve regurgitation and pulmonary venous hypertension.
Hachenberg T; Möllhoff T; Holst D; Hammel D; Brüssel T
J Cardiothorac Vasc Anesth; 1997 Jun; 11(4):453-7. PubMed ID: 9187994
[TBL] [Abstract][Full Text] [Related]
3. Dobutamine as bridge to angiotensin-converting enzyme inhibitor-nitrate therapy in endstage heart failure.
Levine TB; Levine AB; Elliott WG; Narins B; Stomel RJ
Clin Cardiol; 2001 Mar; 24(3):231-6. PubMed ID: 11288970
[TBL] [Abstract][Full Text] [Related]
4. The failing heart and the hemodynamic response to vasodilator therapy.
Mills RM
Clin Cardiol; 2003 Jun; 26(6):257-8. PubMed ID: 12839041
[No Abstract] [Full Text] [Related]
5. Beneficial cumulative role of both nitroglycerin and dobutamine on right ventricular systolic function in congestive heart failure patients awaiting heart transplantation.
Juillière Y; Feldmann L; Perrin O; Berder V; Danchin N; Cherrier F
Int J Cardiol; 1995 Nov; 52(1):17-22. PubMed ID: 8707430
[TBL] [Abstract][Full Text] [Related]
6. Current medical therapy for advanced heart failure.
Gheorghiade M; Cody RJ; Francis GS; McKenna WJ; Young JB; Bonow RO
Heart Lung; 2000; 29(1):16-32. PubMed ID: 10636954
[No Abstract] [Full Text] [Related]
7. A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure.
Loh E; Elkayam U; Cody R; Bristow M; Jaski B; Colucci WS
J Card Fail; 2001 Jun; 7(2):114-21. PubMed ID: 11420762
[TBL] [Abstract][Full Text] [Related]
8. Preliminary evidence for the mechanism underlying the development of tolerance to prazosin in congestive heart failure: the alpha-agonistic properties of dobutamine unmasked by prazosin treatment.
Kersting F; Kupp M; Giesen G
J Cardiovasc Pharmacol; 1993 Apr; 21(4):537-43. PubMed ID: 7681897
[TBL] [Abstract][Full Text] [Related]
9. Vasodilator therapy for chronic left ventricular failure.
Kovick RB; Tillisch JH; Berens SC; Bramowitz AD; Shine KI
Circulation; 1976 Feb; 53(2):322-8. PubMed ID: 812614
[TBL] [Abstract][Full Text] [Related]
10. Drug regimens for congestive heart failure.
Unverferth DV; Magorien RD; Leier CV
Geriatrics; 1980 Jul; 35(7):26-33. PubMed ID: 7380254
[No Abstract] [Full Text] [Related]
11. Haemodynamic advantages of a combined inotropic/venodilator regimen over inotropic monotherapy in acute heart failure.
Verma SP; Silke B; Nelson GI; Hussain M; Richmond A; Taylor SH
J Cardiovasc Pharmacol; 1985; 7(5):943-7. PubMed ID: 2413305
[TBL] [Abstract][Full Text] [Related]
12. B-type natriuretic peptide: from bench to bedside.
Adams KF; Mathur VS; Gheorghiade M
Am Heart J; 2003 Feb; 145(2 Suppl):S34-46. PubMed ID: 12594450
[No Abstract] [Full Text] [Related]
13. Hemodynamic action of captopril in coronary patients with heart failure tolerant to nitroglycerin.
Störk T; Eichstädt H; Möckel M; Gareis R; Bodemann T; Müller R
Clin Cardiol; 1997 Dec; 20(12):999-1004. PubMed ID: 9422837
[TBL] [Abstract][Full Text] [Related]
14. Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacologic agents.
Murali S; Uretsky BF; Reddy PS; Tokarczyk TR; Betschart AR
Am Heart J; 1991 Nov; 122(5):1375-81. PubMed ID: 1951003
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients.
Frey B; Pacher R; Locker G; Bojic A; Hartter E; Woloszczuk W; Stanek B
Chest; 2000 Jun; 117(6):1713-9. PubMed ID: 10858407
[TBL] [Abstract][Full Text] [Related]
16. Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine.
Stanek B; Sturm B; Frey B; Hülsmann M; Bojic A; Berger R; Rödler S; Locker G; Grimm M; Laufer G; Pacher R
J Heart Lung Transplant; 1999 Apr; 18(4):358-66. PubMed ID: 10226901
[TBL] [Abstract][Full Text] [Related]
17. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group.
Karlsberg RP; DeWood MA; DeMaria AN; Berk MR; Lasher KP
Clin Cardiol; 1996 Jan; 19(1):21-30. PubMed ID: 8903534
[TBL] [Abstract][Full Text] [Related]
19. [Acute heart failure].
Brazdzionyte J; Macas A; Mickeviciene A
Medicina (Kaunas); 2006; 42(8):682-91. PubMed ID: 16963836
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure.
Larsen AI; Gøransson L; Aarsland T; Tamby JF; Dickstein K
Am Heart J; 1997 Sep; 134(3):435-41. PubMed ID: 9327699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
